M

Mankind Pharma Ltd
NSE:MANKIND

Watchlist Manager
Mankind Pharma Ltd
NSE:MANKIND
Watchlist
Price: 2 910.6 INR -2.93% Market Closed
Market Cap: 1.2T INR
Have any thoughts about
Mankind Pharma Ltd?
Write Note

Income Statement

Earnings Waterfall
Mankind Pharma Ltd

Revenue
110.2B INR
Cost of Revenue
-32.5B INR
Gross Profit
77.7B INR
Operating Expenses
-54.6B INR
Operating Income
23B INR
Other Expenses
-1.9B INR
Net Income
21.1B INR

Income Statement
Mankind Pharma Ltd

Rotate your device to view
Income Statement
Currency: INR
Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
103 348
N/A
106 496
+3%
110 180
+3%
Gross Profit
Cost of Revenue
(33 979)
(32 023)
(32 523)
Gross Profit
69 369
N/A
74 473
+7%
77 657
+4%
Operating Income
Operating Expenses
(47 895)
(53 039)
(54 641)
Selling, General & Administrative
(33 069)
(23 740)
(24 485)
Depreciation & Amortization
(3 982)
(4 186)
(4 278)
Other Operating Expenses
(10 844)
(25 113)
(25 878)
Operating Income
21 474
N/A
21 434
0%
23 016
+7%
Pre-Tax Income
Interest Income Expense
1 739
(237)
(231)
Non-Reccuring Items
(83)
0
0
Gain/Loss on Disposition of Assets
94
0
0
Total Other Income
769
3 228
3 723
Pre-Tax Income
23 994
N/A
24 425
+2%
26 508
+9%
Net Income
Tax Provision
(4 576)
(4 519)
(5 125)
Income from Continuing Operations
19 418
19 907
21 384
Income to Minority Interest
(289)
(281)
(234)
Net Income (Common)
19 129
N/A
19 625
+3%
21 150
+8%
EPS (Diluted)
47.68
N/A
48.91
+3%
52.7
+8%

See Also

Discover More